Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

828
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
828
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

702
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
702
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

583
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
583
  1. Home
  2. Research Domains
  3. Agricultural, Veterinary And Food Sciences
  4. Veterinary Sciences
  5. Veterinary Medicine (excl. Urology)
  6. Prevalence Of Vernal Keratoconjunctivitis In Canada: A Cross-sectional Survey Study

Prevalence of vernal keratoconjunctivitis in Canada: a cross-sectional survey study

Manokamna Agarwal1, Ya-Ping Jin2, Larissa Gouvea1

  • 1Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children, Toronto, ON, Canada; Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON, Canada.

Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie
|July 6, 2025

Related Experiment Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.4K
Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

2.2K

View abstract on PubMed

Summary
This summary is machine-generated.

Vernal keratoconjunctivitis (VKC) affects Canadians, with prevalence estimates varying by age group. The best estimate for VKC in Canada was 0.90 per 10,000 people, and 4.33 per 10,000 children and teens.

Area of Science:

  • Ophthalmology
  • Allergy and Immunology
  • Public Health

Background:

  • Vernal keratoconjunctivitis (VKC) is a severe allergic eye condition primarily affecting children and adolescents.
  • Estimating VKC prevalence is challenging due to its episodic nature and varying diagnostic criteria.

Purpose of the Study:

  • To estimate the national prevalence of active vernal keratoconjunctivitis (VKC) in Canada as of January 2023.
  • To provide data on VKC prevalence across different age demographics, particularly in pediatric populations.

Main Methods:

  • A national online survey was distributed to 1,061 ophthalmologists registered with the Canadian Ophthalmological Society.
  • Eighty (7.5%) ophthalmologists responded, providing data used to estimate VKC prevalence under six distinct hypotheses.
  • Hypotheses considered variations in disease duration and potential underreporting by non-responders.

Related Experiment Videos

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
06:29

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19

Published on: May 25, 2022

2.4K
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
07:35

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva

Published on: July 5, 2017

10.4K
Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells
09:31

Determining the Toxicity of UV Radiation and Chemicals on Primary and Immortalized Human Corneal Epithelial Cells

Published on: July 22, 2021

2.2K

Main Results:

  • Estimated VKC prevalence per 10,000 population ranged from 0.13 to 3.34 for all Canadians and 0.61 to 16.11 for those aged 0-19.
  • The most robust estimate, assuming a 4-year disease duration and accounting for non-responder data, was 0.90 per 10,000 for the general population and 4.33 per 10,000 for children and teens.
  • Common VKC complications included shield ulcer and steroid-induced ocular hypertension.

Conclusions:

  • This study provides the most current national prevalence estimates for VKC in Canada.
  • The findings highlight a significant prevalence of VKC, especially in the pediatric population.
  • The data underscore the importance of understanding VKC's impact and associated complications in public health planning.